Immutrix Therapeutics
Rapid City, US · South Dakota corporation
Founders & leadership
DS
Dan SmithChief Operating Officer
RL
Ronald L ShapePresident, CEO and CFO
LK
Leroy KetelCFO, Secretary
Board
BH
Brad HennrichBoard director
RO
Rich OttoBoard director
CR
Carol RaeBoard director
LB
Lonnie BookbinderBoard director
SL
Stephanie Lien D'UrsoBoard director
RM
Russell McCullohBoard director
BP
Brent PhillipsBoard director
Reported raises · per SEC filings
Form D private placements$14.5M disclosed across 6 rounds · 2014–2025
▶$480KraisedSep 2025 · 1 investors · OtherRule 506(b)
▶$480KraisedSep 2025 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Dan SmithExecutive Officer
- Brad HennrichDirector
- Rich OttoDirector
- Carol RaeDirector
- Lonnie BookbinderDirector
- Ronald L ShapeExecutive Officer, Director
- Stephanie Lien D'UrsoDirector
- Russell McCullohDirector
- Offering amount
- $5M
- Amount sold
- $480K
- Minimum investment
- $50K
- Proceeds to insiders
- $800K
- First sale
- Sep 2025
- Incorporated
- Corporation, South Dakota
- Federal exemptions
- 06b
▶$300KraisedJul 2020 · 1 investors · BiotechnologyRule 506(b)
▶$300KraisedJul 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig HansenDirector
- Brent R. PhillipsDirector
- Roy KetelExecutive Officer, Director
- Carol A RaeExecutive Officer, Director
- Stephanie Lien D?ursoDirector
- Offering amount
- $15M
- Amount sold
- $300K
- Minimum investment
- $25K
- Proceeds to insiders
- $975K
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$450KraisedSep 2019 · 2 investors · BiotechnologyRule 506(b)
▶$450KraisedSep 2019 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carol A. RaeExecutive Officer, Director
- Brent R. PhillipsDirector
- Craig K. HansenDirector
- James L. ScullDirector
- Leroy B. KetelExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $450K
- Minimum investment
- $200K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.3MraisedOct 2018 · 26 investors · BiotechnologyRule 506(b)
▶$5.3MraisedOct 2018 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brent PhillipsDirector
- Leroy KetelExecutive Officer, Director
- Carol A. RaeExecutive Officer, Director
- Offering amount
- $16M
- Amount sold
- $5.3M
- Minimum investment
- $50K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.1MraisedJul 2016 · 34 investors · BiotechnologyRule 506(b)
▶$4.1MraisedJul 2016 · 34 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carol RaeExecutive Officer, Director
- Brent PhillipsDirector
- Leroy KetelExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4.1M
- Minimum investment
- $1.5K
- Proceeds to insiders
- $506.4K
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.9MraisedOct 2015 · 1 investors · BiotechnologyRule 506(b)
▶$3.9MraisedOct 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carol RaeExecutive Officer, Director
- Leroy KetelExecutive Officer, Director
- Brent PhillipsDirector
- Offering amount
- $6.5M
- Amount sold
- $3.9M
- Minimum investment
- $2.6M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Immutrix Therapeutics raised?
- Immutrix Therapeutics has disclosed $14.5M raised across 6 rounds.
- Where is Immutrix Therapeutics headquartered?
- Immutrix Therapeutics is headquartered in Rapid City, US.